Minnesota’s biotechnology industry is a dynamic sector focusing on the innovation of health solutions, agricultural enhancements, and research tools. Companies here range from small start-ups to larger firms specialized in areas like genetic research, regenerative medicine, and microbiome therapies. The state’s strong emphasis on life sciences drives advancements in drug development and therapeutics. Study results indicate that the demand for biotechnological interventions is growing, highlighting a significant market opportunity for the future. Minnesota’s unique ecosystem fosters collaboration among research institutions, complementing its various biotech startups and established corporations.


This list features 22 biotechnology companies across Minnesota, showcasing a mix of young dynamic firms and established enterprises. With sizes varying from small teams of fewer than ten to workforce giants of over 1,000, these companies are found in key cities like Minneapolis, Rochester, and Eagan. Many firms founded after 2000 focus on specific specializations, including gene editing, cell culture, and health technologies, portraying a vibrant pulse in innovation and research. Together, they play an integral role in advancing medical solutions and agricultural productivity.


Continue reading to discover more about Minnesota's top biotechnology companies.


Top 22 Biotechnology Companies Companies in Minnesota


1. Rebiotix Inc (a Ferring Company)

  • Website: rebiotix.com
  • Ownership type: Corporate
  • Headquarters: Roseville, Minnesota, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: April 2018
  • Founded year: 2011
  • Headcount: 11-50
  • LinkedIn: rebiotix

Rebiotix Inc. is a biotechnology firm based in Roseville, Minnesota, that focuses on developing microbiome-based therapeutics. Founded in 2011, the company aims to create innovative treatments for recurrent Clostridioides difficile infections, a serious gut infection that can lead to severe complications. Rebiotix's primary approach involves fecal transplant therapies, which aim to restore a healthy balance of microorganisms in the gut. This method has shown promise in preventing infection recurrence, addressing a significant healthcare challenge. As part of Ferring Pharmaceuticals since its acquisition in 2018, Rebiotix benefits from enhanced resources and expertise in the pharmaceutical industry, allowing it to advance its research and development efforts in microbiome therapies. The company is dedicated to improving patient outcomes and is actively involved in clinical studies to validate its therapeutic approaches.


2. R&D Systems

  • Website: rndsystems.com
  • Ownership type: Private
  • Headquarters: Minneapolis, Minnesota, United States (USA)
  • Employee distribution: United States (USA) 78%, India 9%, China 7%, Other 7%
  • Founded year: 1985
  • Headcount: 1001-5000
  • LinkedIn: r%26d-systems

R&D Systems, based in Minneapolis, Minnesota, is a biotechnology company that specializes in the development and manufacturing of high-quality research reagents and tools for the life sciences sector. Established in 1985, the company has built a reputation for providing a wide range of products, including recombinant proteins, antibodies, and custom services. These offerings are designed to support researchers in biotechnology, pharmaceuticals, and academic institutions. R&D Systems emphasizes quality and consistency in its products, which is essential for advancing scientific research across various fields. The company also provides custom services tailored to the specific needs of its clients, further enhancing its relevance in the biotechnology space. With a workforce of over 600 employees and a significant presence in the global market, R&D Systems continues to play a vital role in the life sciences industry.


3. Recombinetics

  • Website: recombinetics.com
  • Ownership type: Venture Capital
  • Headquarters: Eagan, Minnesota, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: Series A, $34.0M, August 2018
  • Founded year: 2008
  • Headcount: 11-50
  • LinkedIn: recombinetics-inc.

Recombinetics, founded in 2008 and based in Eagan, Minnesota, is a biotechnology company that specializes in gene editing solutions for both biomedical research and agricultural applications. The company offers a range of services, including preclinical research and the development of gene-edited animal models. Their innovative technologies aim to enhance health outcomes and improve sustainability in food production. Recombinetics has developed a proprietary gene editing platform that is pivotal for their BioVentures, which focus on transforming healthcare and agricultural practices. Their clientele includes researchers and agricultural producers who seek advanced solutions to pressing challenges. The company has received significant funding, totaling $34 million in a Series A round in 2018, which reflects strong investor interest in their technology and business model. Recombinetics is recognized for its contributions to the field, particularly in creating genetically modified animals that can lead to breakthroughs in both human health and agricultural efficiency.


4. Cytotheryx, Inc.

  • Website: cytotheryx.com
  • Ownership type: Private
  • Headquarters: Rochester, Minnesota, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 2019
  • Headcount: 11-50
  • LinkedIn: cytotheryx

Cytotheryx, Inc., based in Rochester, Minnesota, is a biotechnology firm established in 2019. The company specializes in the development of primary human hepatocytes, which are essential for treating liver diseases and conducting research. Cytotheryx aims to provide innovative solutions such as bioartificial livers and hepatocyte transplantation therapies. Their platform technology allows for the production of high-quality liver cells at scale, addressing the critical need for reliable hepatocytes in medical applications. The company collaborates with prominent healthcare providers and researchers, enhancing its credibility and potential impact in the field of liver disease treatment. With a dedicated team and a clear mission, Cytotheryx is positioned to contribute significantly to advancements in liver health and regenerative medicine.


5. Imanis Life Sciences

  • Website: imanislife.com
  • Ownership type: Private
  • Headquarters: Rochester, Minnesota, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: $1.0M, March 2014
  • Founded year: 2012
  • Headcount: 11-50
  • LinkedIn: imanis-life-sciences-llc

Imanis Life Sciences, founded in 2012 and based in Rochester, Minnesota, is a private biotechnology company dedicated to advancing life sciences research. The company specializes in the development and provision of high-quality products such as cell lines, lentiviral vectors, and oncolytic viruses. They also offer a range of services, including custom product development and assay validation, which are crucial for researchers in the biotechnology and pharmaceutical sectors. Imanis serves a clientele that relies on their expertise for the development of therapies in regenerative medicine, gene therapy, and oncology. Their scientific team comprises skilled professionals in virology, immunology, and molecular biology, all working in state-of-the-art laboratories to ensure quality and adaptability in their offerings. Imanis Life Sciences is committed to supporting the research community by providing essential tools and services that facilitate the discovery and development of innovative therapies.


6. Rion

  • Website: riontx.com
  • Ownership type: Venture Capital
  • Headquarters: Rochester, Minnesota, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: Seed, $1,000, June 2017
  • Founded year: 2017
  • Headcount: 11-50
  • LinkedIn: rion-health

Rion, established in 2017 in Rochester, Minnesota, is a clinical-stage regenerative medicine company that specializes in exosome technology. The company emerged from the Mayo Clinic Employee Entrepreneurial Program, leveraging research from the Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program. Rion's flagship product, the Purified Exosome Product (PEP™), is derived from platelets and is designed to promote tissue regeneration. This innovative product can be administered through various routes, including topical and intravenous, targeting multiple types of tissues such as skin, heart, and muscle. Rion has developed a proprietary manufacturing process that allows for the mass production of PEP™, addressing scalability challenges in the industry. With a focus on enhancing healing and recovery, Rion aims to transform the approach to regenerative medicine and improve patient outcomes across a range of conditions.


7. BIO-CAT Microbials


BIO-CAT Microbials, founded in 2004 and based in Shakopee, Minnesota, is a private biotechnology company that specializes in the development and manufacturing of enzymes, probiotics, and microbials. The company offers a wide range of products tailored for various applications, including dietary supplements, food and beverage processing, animal nutrition, and agricultural enhancements. BIO-CAT is dedicated to improving product quality and efficiency through innovative solutions, emphasizing custom formulation and product development. Their expertise extends to clinical studies and regulatory support, ensuring that their products meet industry standards. With a focus on non-genetically engineered, kosher, halal, and vegan options, BIO-CAT caters to a growing market that values quality and safety in biotechnology products. The company has a history of scientific innovation, with its founders bringing decades of experience in enzyme development and processing to the table.


8. Humanetics Corporation

  • Website: humaneticscorp.com
  • Ownership type: Private
  • Headquarters: Minneapolis, Minnesota, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: Other (Grant), $5.0M, December 2024
  • Founded year: 1988
  • Headcount: 11-50
  • LinkedIn: humanetics-corporation

Humanetics Corporation, based in Minneapolis, Minnesota, is a private pharmaceutical company founded in 1988. The firm is dedicated to developing and commercializing innovative treatments aimed at enhancing human health, particularly in the areas of cancer and radiation exposure. Humanetics has made significant strides in the biotechnology industry, especially since entering the field of radiation modulators in 2003 through a collaboration with the Armed Forces Radiobiology Research Institute. Their primary product, BIO 300, is a novel drug that aims to improve outcomes for cancer patients undergoing radiation therapy and serves as a countermeasure against radiation injuries. The company has received over $60 million in non-dilutive funding from various federal agencies, including the Department of Defense and the National Cancer Institute, to support its research and development initiatives. Humanetics is currently engaged in multiple clinical trials and has a robust pipeline focused on oncology and inflammatory lung diseases, showcasing its commitment to addressing urgent health needs.


9. Douglas Scientific

  • Website: douglasscientific.com
  • Ownership type: Corporate
  • Headquarters: Alexandria, Minnesota, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: April 2016
  • Founded year: 2009
  • Headcount: 51-200
  • LinkedIn: douglas-scientific

Douglas Scientific, based in Alexandria, Minnesota, is a biotechnology service provider founded in 2009. The company focuses on the discovery, development, and manufacture of nucleic acid-based therapeutics. Their services include analytics, gene editing, and bioinformatics, catering primarily to pharmaceutical and biotechnology companies. Douglas Scientific emphasizes high-quality service delivery and scientific excellence, leveraging their expertise to support clients in advancing their drug development projects. With a dedicated team and state-of-the-art equipment, they aim to provide tailored solutions that meet the specific needs of their clients in the competitive biotechnology sector.


10. Invenshure, LLC

  • Website: invenshure.com
  • Ownership type: Private
  • Headquarters: Minneapolis, Minnesota, United States (USA)
  • Employee distribution: United States (USA) 65%, Hungary 35%
  • Latest funding: Other (Debt), $200,000, June 2019
  • Founded year: 2012
  • Headcount: 11-50
  • LinkedIn: invenshure-llc

Invenshure, LLC, founded in 2012 and based in Minneapolis, Minnesota, operates at the intersection of biotechnology and insurance. The company is dedicated to building and accelerating innovative companies that address significant challenges in healthcare. Their portfolio includes firms focused on precision oncology, genetic counseling, and medical imaging, among others. Invenshure leverages institutional intellectual property to transform scientific discoveries into viable commercial products. They have a notable presence in the biotechnology sector, with companies like MEKanistic Therapeutics, which is developing novel cancer therapies, and GeneMatters, which provides telehealth genetic counseling services. Invenshure has also received funding, with a reported last funding amount of $200,000 in June 2019, indicating ongoing investment in their initiatives.


11. Jord BioScience

  • Website: jordbioscience.com
  • Ownership type: Venture Capital
  • Headquarters: Saint Paul, Minnesota, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: Series B, $7.0M, February 2025
  • Founded year: 2019
  • Headcount: 1-10
  • LinkedIn: jord-bioscience

Jord BioScience is an agricultural biotechnology firm based in Saint Paul, Minnesota, established in 2019. The company specializes in developing microbial solutions aimed at improving crop health and productivity. With a strong foundation in research, Jord BioScience leverages nearly four decades of scientific inquiry into soil microbes to create products that enhance the performance of existing agricultural inoculants. Their technology has demonstrated significant improvements in crop yield and health, making them a valuable partner for agricultural companies seeking to innovate and differentiate their offerings. Recently, Jord BioScience raised $7 million in a Series B funding round, underscoring the market's interest in their sustainable agricultural solutions. The company is committed to advancing regenerative agriculture through its proprietary microbial technologies, which are designed to work synergistically with commercial products to optimize plant performance across various crop systems.


12. Nu-Tek BioSciences

  • Website: nu-tekbiosciences.com
  • Ownership type: Private
  • Headquarters: Minnetonka, Minnesota, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 2009
  • Headcount: 11-50
  • LinkedIn: nutek-bioscience

Nu-Tek BioSciences, founded in 2009 and based in Minnetonka, Minnesota, is a biotechnology company focused on manufacturing animal-free peptones and cell culture media tailored for pharmaceutical applications. The company operates the only completely animal-free peptone manufacturing facility in the United States, which allows them to mitigate contamination risks associated with animal-derived products. Their product offerings include soy, pea, wheat, and rice peptones, as well as yeast extracts, all designed to support drug development and industrial fermentation processes. Nu-Tek's commitment to sustainability and efficiency is evident in their plant-based solutions, which provide regulatory advantages and enhance supply chain resilience for their clients. They actively engage with pharmaceutical manufacturers and supply houses, offering custom manufacturing services to meet specific project needs. Their innovative approach and focus on animal-free products position them as a significant player in the biotechnology sector.


13. Cell Culture Company

  • Website: cellculturecompany.com
  • Ownership type: Private
  • Headquarters: Minneapolis, Minnesota, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 2016
  • Headcount: 11-50
  • LinkedIn: cellcultureco

Cell Culture Company, LLC, based in Minneapolis, Minnesota, is a biotechnology firm founded in 2016. The company specializes in cell culture and antibody production, offering a range of services that cater to researchers and organizations in the life sciences sector. Their offerings include cell line development, cell banking, and protein purification, which are vital for advancing research and diagnostics. The company has prioritized the production of COVID-19 reagents, showcasing its responsiveness to current health challenges. With a focus on high-quality biomolecule production, Cell Culture Company operates under stringent quality standards, including GMP, GLP, and ISO certifications. Their advanced technologies facilitate efficient production processes, making them a valuable partner for clients in need of reliable biotechnological solutions.


14. Be The Match BioTherapies


Be The Match BioTherapies, founded in 2016 and based in Minneapolis, Minnesota, is a private consulting company dedicated to the biopharmaceutical and biotechnology sectors. With a workforce of between 1,001 and 5,000 employees, the firm specializes in offering educational webinars and consulting services tailored to the needs of biopharma companies, transplant centers, and regulatory bodies. Their expertise lies in navigating the complexities of cell therapies, which are crucial for improving patient outcomes in various medical contexts. By providing resources and guidance, Be The Match BioTherapies plays a significant role in advancing the understanding and implementation of innovative therapies in the industry.


15. Life Epigenetics

  • Website: lifeegx.com
  • Ownership type: Private
  • Headquarters: Minneapolis, Minnesota, United States (USA)
  • Founded year: 2016
  • Headcount: 11-50
  • LinkedIn: life-epigenetics

Life Epigenetics, also known as FOXO Technologies, is a private biotechnology firm based in Minneapolis, Minnesota, founded in 2016. The company specializes in life insurance products that leverage epigenetic technology to provide valuable insights into health and aging. Their offerings include the Longevity Report and epigenetic testing, which cater to both individuals seeking health insights and insurance companies aiming to refine their underwriting processes. By utilizing saliva-based epigenetic testing, FOXO Technologies aims to revolutionize how life insurance is underwritten, moving away from traditional invasive methods. Their technology is rooted in advanced machine learning and bioinformatics, allowing for the analysis of DNA methylation patterns that correlate with biological aging. This innovative approach not only enhances the accuracy of mortality predictions but also empowers individuals with personalized health information. As they continue to develop their services, FOXO Technologies is positioned at the forefront of integrating biotechnology with insurance, making significant strides in the understanding of longevity and health management.


16. Biovest International

  • Website: hollow-fiber.com
  • Ownership type: Private
  • Headquarters: Minneapolis, Minnesota, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 1981
  • Headcount: 51-200
  • LinkedIn: biovest-international

Biovest International, based in Minneapolis, Minnesota, is a biotechnology company that has been active since 1981. The firm specializes in the development and manufacturing of hollow fiber bioreactors, which are crucial for cell culture and bioprocessing applications. Their products are designed to enhance productivity in protein production, catering to sectors such as diagnostics, therapeutics, and research. Biovest's hollow fiber technology allows for efficient nutrient supply and waste removal, mimicking natural physiological conditions, which is vital for high cell density and productivity. The company serves a global clientele, providing solutions that support both research and commercial production needs. With a dedicated team and a commitment to quality, Biovest International continues to play a significant role in advancing biotechnological processes.


17. Biolyph

  • Website: biolyph.com
  • Ownership type: Private
  • Headquarters: Chaska, Minnesota, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 1993
  • Headcount: 51-200
  • LinkedIn: biolyph

Biolyph, founded in 1993 and based in Chaska, Minnesota, is a biotechnology company that specializes in innovative lyophilization services tailored for the life science and medical device industries. The company focuses on converting unstable proteins, antibodies, enzymes, and other reagents into stable LyoSpheres, which are microliter aliquots designed for easy rehydration and use. Biolyph's services are vital for in vitro diagnostics (IVD) and research use only (RUO) applications, providing essential support for manufacturers in these fields. Their expertise extends to excipient formulation, cycle development, and specialized packaging, ensuring high-quality products that meet stringent regulatory standards. Biolyph's commitment to quality is reflected in their adherence to FDA and ISO requirements, making them a reliable partner for clients producing regulated products. With a workforce of around 35 employees, Biolyph continues to innovate in lyophilization technology, demonstrating their relevance and capability in the biotechnology sector.


18. BioSim Innovations


BioSim Innovations is a private biotechnology company based in Brooklyn Park, Minnesota, established in 2020. The firm specializes in providing innovative preclinical models and testing services tailored for medical devices and therapies. With a team of approximately 22 employees, BioSim Innovations operates a cutting-edge laboratory that offers a comprehensive range of services, from study design to clinical imaging. Their clientele primarily consists of medical device companies and researchers who require advanced simulation and imaging capabilities to support their product development efforts. The company is committed to driving innovation and efficiency in the preclinical testing phase, which is crucial for the successful transition of medical technologies from concept to clinical application.


19. Kindeva Drug Delivery

  • Website: kindevadd.com
  • Ownership type: Corporate
  • Headquarters: Woodbury, Minnesota, United States (USA)
  • Employee distribution: United States (USA) 66%, United Kingdom (UK) 34%
  • Latest funding: Other (Grant), $42.0M, August 2023
  • Founded year: 2020
  • Headcount: 1001-5000
  • LinkedIn: kindeva

Kindeva Drug Delivery, founded in 2020 and based in Woodbury, Minnesota, operates as a contract development and manufacturing organization (CDMO) specializing in drug-device combination products. The company offers a wide range of services, including aseptic injectable fill-finish, analytical support, and sustainability initiatives. Kindeva's expertise spans various drug delivery formats, such as pulmonary and nasal delivery systems, injectables, microneedle array patches, and transdermal therapies. With a workforce of over 1,200 employees and facilities in the United States and the United Kingdom, Kindeva is well-equipped to support pharmaceutical and biotechnology companies in accelerating product development while ensuring compliance with regulatory standards. Recently, Kindeva secured funding of approximately $41.96 million in August 2023, indicating ongoing investment in their capabilities and growth.


20. Iterro Life Sciences

  • Website: iterrolife.com
  • Ownership type: Private
  • Headquarters: Balaton, Minnesota, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 2018
  • Headcount: 11-50
  • LinkedIn: the-tru-shrimp-company

Iterro Life Sciences, founded in 2018 and based in Balaton, Minnesota, is a biotechnology company that specializes in shrimp farming technology and biopolymer formulation. The firm is recognized for its innovative Tidal Basin® technology, which allows for commercial-scale, shallow-water indoor shrimp farming. This technology not only increases shrimp production but also ensures that the shrimp are 100% traceable and free from antibiotics. Iterro's product offerings include trū Chitosan, trū Shrimp, and trū Protein, catering to both consumers and businesses seeking sustainable seafood options. The company aims to transform the shrimp industry by addressing contamination issues and promoting environmental sustainability, making a significant impact on the global food supply and local communities.


21. Evergen (Formerly Collagen Solutions)

  • Website: collagensolutions.com
  • Ownership type: Corporate
  • Headquarters: Eden Prairie, Minnesota, United States (USA)
  • Employee distribution: United States (USA) 58%, United Kingdom (UK) 36%, New Zealand 6%
  • Latest funding: October 2024
  • Founded year: 2014
  • Headcount: 51-200
  • LinkedIn: collagen-solutions-plc

Evergen, previously known as Collagen Solutions, is a biotechnology firm based in Eden Prairie, Minnesota. Founded in 2014, the company specializes in engineered medical-grade collagen and tissue-based products tailored for medical devices. Evergen collaborates closely with medical device manufacturers to create custom formulations, ensuring that their products meet the specific needs of the healthcare sector. Their offerings include a wide range of collagen-based biomaterials used in applications such as orthopedics, dental care, and wound management. The company operates under rigorous quality standards, maintaining certifications like ISO 13485, which underscores their commitment to producing high-quality biomaterials. With facilities in the United States, the United Kingdom, and New Zealand, Evergen is well-positioned to serve a global market, providing both off-the-shelf and custom solutions for their clients.


22. M2I Life Sciences

  • Website: m2i-group.fr
  • Ownership type: Private
  • Headquarters: St. Cloud, Minnesota, United States (USA)
  • Employee distribution: France 95%, United States (USA) 4%, Other 1%
  • Founded year: 2012
  • Headcount: 51-200
  • LinkedIn: m2i-life-sciences

M2I Life Sciences, founded in 2012 and based in St. Cloud, Minnesota, is a private biotechnology firm that specializes in biocontrol solutions aimed at enhancing animal and plant health. The company focuses on the development and manufacturing of pheromones and other biological products, which are crucial for agricultural businesses and veterinarians in managing pests and improving animal well-being. M2I Life Sciences operates with a strong emphasis on research and development, supported by their production capabilities. They have established a significant presence in the biocontrol market, particularly in the synthesis and application of pheromones for pest management. Their innovative products are designed to be environmentally friendly, addressing the growing demand for sustainable agricultural practices. M2I Life Sciences has also received multiple awards for their contributions to the industry, highlighting their commitment to innovation and ecological responsibility.



Biotechnology Companies Insights: Key Companies in Minnesota


CompanyHeadquarterSizeFoundedOwnership
Rebiotix Inc (a Ferring Company)Roseville, Minnesota, United States (USA)11-502011Corporate
R&D SystemsMinneapolis, Minnesota, United States (USA)1001-50001985Private
RecombineticsEagan, Minnesota, United States (USA)11-502008Venture Capital
Cytotheryx, Inc.Rochester, Minnesota, United States (USA)11-502019Private
Imanis Life SciencesRochester, Minnesota, United States (USA)11-502012Private
RionRochester, Minnesota, United States (USA)11-502017Venture Capital
BIO-CAT MicrobialsShakopee, Minnesota, United States (USA)11-502004Private
Humanetics CorporationMinneapolis, Minnesota, United States (USA)11-501988Private
Douglas ScientificAlexandria, Minnesota, United States (USA)51-2002009Corporate
Invenshure, LLCMinneapolis, Minnesota, United States (USA)11-502012Private
Jord BioScienceSaint Paul, Minnesota, United States (USA)1-102019Venture Capital
Nu-Tek BioSciencesMinnetonka, Minnesota, United States (USA)11-502009Private
Cell Culture CompanyMinneapolis, Minnesota, United States (USA)11-502016Private
Be The Match BioTherapiesMinneapolis, Minnesota, United States (USA)1001-50002016Private
Life EpigeneticsMinneapolis, Minnesota, United States (USA)11-502016Private
Biovest InternationalMinneapolis, Minnesota, United States (USA)51-2001981Private
BiolyphChaska, Minnesota, United States (USA)51-2001993Private
BioSim InnovationsBrooklyn Park, Minnesota, United States (USA)11-502020Private
Kindeva Drug DeliveryWoodbury, Minnesota, United States (USA)1001-50002020Corporate
Iterro Life SciencesBalaton, Minnesota, United States (USA)11-502018Private
Evergen (Formerly Collagen Solutions)Eden Prairie, Minnesota, United States (USA)51-2002014Corporate
M2I Life SciencesSt. Cloud, Minnesota, United States (USA)51-2002012Private


Want to Find More Biotechnology Companies Companies?

If you want to find more companies that ...provide innovative solutions in genetics, therapies, and research tools you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.

With Inven you'll also get to know the company's:

  • Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
  • Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
  • Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!